Elicio Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Elicio Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Elicio Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $379K, a 21.5% increase year-over-year.
  • Elicio Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.38M, a 24.8% increase from 2022.
  • Elicio Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $1.11M, a 6.19% decline from 2021.
  • Elicio Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.18M, a 9.07% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.38M +$274K +24.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $1.11M -$73K -6.19% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $1.18M +$98K +9.07% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $1.08M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.